THE INVESTMENT APPROACH OF CALVIN TAN

SUPERMAX (7106) VERSUS KOSSAN (7153) Compare & Contrast Their Accounts & Prospects, Calvin Tan Research

calvintaneng
Publish date: Sat, 16 May 2020, 10:51 AM
calvintaneng
0 1,808
Hi Guys,

I have An Investment Approach I which I would like to all.

Hi guys

So happy Bull Time has returned to Malaysian Glove Companies due to Coronavirus

While many Businesses are going bankrupt & closing Shop THE BEST BUSINESS ON PLANET EARTH TODAY IS SELLING MEDICAL EXAMINATION & SURGICAL GLOVES

And this is not an option or choice. THIS IS AN IMPERATIVE! AN EMERGENCY TO SAVE LIVES BY THE COLLECTIVE WORLD GOVERNMENTS OF 7 BILLION PEOPLE ON EARTH

AND AS LONG AS COVID 19 LINGERS THE DEMAND WILL CONTINUE AND SO IS THE GLOVE BULL RUN

 

Now let's look at These Two Stocks = SuperMax & Kossan

Why picked these two for comparison

Because their balance sheet look similar but the Difference is the Price.

 

SUPERMAX (Please go to latest qtr report)

SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2019

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Dec 2019
31 Dec 2018
31 Dec 2019
31 Dec 2018
$$'000
$$'000
$$'000
$$'000
1 Revenue
385,497
385,101
755,438
752,153
2 Profit/(loss) before tax
41,829
54,317
74,272
106,993
3 Profit/(loss) for the period
30,022
38,721
54,982
74,690
4 Profit/(loss) attributable to ordinary equity holders of the parent
30,165
38,136
54,912
74,078
5 Basic earnings/(loss) per share (Subunit)
2.31
2.91
4.21
5.65
6 Proposed/Declared dividend per share (Subunit)
0.00
1.50
0.00
1.50
   
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7 Net assets per share attributable to ordinary equity holders of the parent ($$)
0.8600
0.8300
 

 

Supermax profit is 2.31 sen

If annualised 2.31 x 4 = 9.24 sen

At Rm3.97

Supermax has a P/E of 42.96 

It has Rm1.909 Billlions in PPE, Cash, Receivables, Inventories, Investments & others

It has Rm763 Millions in borrowings, payables & etc

So it has 39.9% of liability to Value

It has Rm167.9 Millions in CASH

At Rm3.97 with NAV of 86 sen it is selling at Price to asset of 4.61 times

 

KOSSAN

SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2019

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Dec 2019
31 Dec 2018
31 Dec 2019
31 Dec 2018
$$'000
$$'000
$$'000
$$'000
1 Revenue
578,349
589,372
2,221,607
2,140,571
2 Profit/(loss) before tax
72,279
71,400
280,107
249,264
3 Profit/(loss) for the period
61,577
61,033
227,922
204,599
4 Profit/(loss) attributable to ordinary equity holders of the parent
61,003
59,514
224,783
198,210
5 Basic earnings/(loss) per share (Subunit)
4.77
4.65
17.58
15.62
6 Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00
   
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7 Net assets per share attributable to ordinary equity holders of the parent ($$)
1.1100
1.0200

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:
 

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence

 

At 4.77 sen annualised

4.77x 4 = 19.08

At Rm7.68 Kossan has a P/E of 40.25

 

It has Rm2.321 Billions in PPE, Receivables, Cash & etc

It has R904 millions in Payables, borrowings & etc

It has 38.9% of liability of Value

Kossan has a Cash hoard of Rm162 millions

Kossan NAV is Rm1.11 or Price to book value of 6.91 times

 

So OK let us look more closely

KOSSAN earning at 4.77 sen looks better than Supermax at 2.31 sen

But that is all

Compare further

Kossan P/E is 40.25 while Supermax is 42.96

That again is a small difference

Kossan NAV is 1.11 sen and SuperMax is 86 sen (Supermax not much lower)

Liability to Value also quite similar Kossan 38.9% while Supermax is 39.9%

Look at this

Kossan price to NAV is 6.91 times while Supermax is only 4.61 times

AND THE BIG DIFFERENCE NOW IS THE PRICE GAP

 

K)SSAN IS RM7.68

SUPERMAX IS RM3.97

KOSSAN SHARE PRICE IS 93% HIGHER THAN SUPERMAX

IS SUPERMAX UNDERVALUE

THE ONLY DIFFERENCE NOW IS KOSSAN PROFIT OF 4.77 SEN COMPARED TO SUPERMAX AT 2.31 SEN

WE SEE TWO BOOSTER FOR SUPERMAX TO CHASE UP

1) SUPERMAX IS SELLING 100% EXAM GLOVES & SURGICAL GLOVES WHICH COMMAND PREMIUM PRICES

2) SUPERMAX ALSO SELL DIRECT THRU RETAIL STORES

READ THIS

Business Background

Supermax Corp Bhd is an investment holding company. The company is an international manufacturer, distributor, and marketer of high-quality medical gloves. It offers various types of latex gloves, which are exported to over 155 countries around the world. The company is organized into the following operating segments, Investment Holding, Manufacturing of Gloves, Trading of Gloves and Others. It has operational footprints across America and Canada, Europe and Asia. The company's largest end market by revenue is the America.
 

Business Background

Kossan Rubber Industries Bhd manufactures industrial rubber products and disposable latex gloves. The firm has three primary businesses: Technical Rubber Products, Gloves, Cleanroom Products, and Others. The Gloves segment generates the majority of revenue. The Technical Rubber Products business manufactures and distributes high technical input rubber products. The Gloves business manufactures medical grade examination gloves and specialty gloves for healthcare and industrial applications. The Cleanroom Products business sells rubber products that can be used in cleanrooms. The majority of Kossan Rubber’s revenue is generated through exports outside of Malaysia.
Notice the difference
SuperMax is 100% into Medical Gloves while Kossan also sell  Technical Rubber Products, Gloves, Cleanroom Products, and Others
NOW COVID 19 Requires More Medical Gloves so SuperMax should by right do better going forward
 
SuperMax price now is Rm3.97
Target price is Rm6.00
If broken then Rm7.00 & above possible
 
Best regards
 
Calvin Tan Research
Singapore
 
Please buy or sell after doing your own due diligence. In doubt please consult your remisier or Fund Manager

 

 

Discussions
1 person likes this. Showing 5 of 5 comments

Targeted

Yes, Pure play medical gloves is the way to go!

2020-05-16 18:53

johnny cash

Thanks calvin

2020-05-16 19:30

Ravi Kumar

The big 4 and smaller players.



Targeted Yes, Pure play medical gloves is the way to go!
16/05/2020 6:53 PM

2020-05-16 22:13

excelyou

Looking at RM9.8 because of possible bonus issue in 2H2020

2020-05-16 23:20

Lewis Lee

Good analysis !

2020-05-17 12:28

Post a Comment